1. ÃâÒßÁÆ·¨ÌáÉýÖ×ÁöÌØÒìÐÔÁÙ´²ÂäµØ
ÔÚ2016ÃÀ¹úÃÚÄòÖ×Áöѧ»áÄê»áÉÏ£¬Heat Biologics¹«Ë¾¹«²¼ÁË»ùÓÚÈÈÐݿ˵°°×(HSP)µÄÃâÒßÁÆ·¨ÐÂÒ©vesigenurtacel-L(ÓÖÃûHS-410)µÄ2ÆÚÁÙ´²³õ²½½á¹û¡£ÔڷǼ¡²ã½þÈó°òë×°©»¼ÕßÖУ¬HS-410ÏÔʾ³öÁËÁîÈ˹ÄÎèµÄ¿¹Ö×Áö»îÐÔ£¬¿ÉÒÔÓÕµ¼»úÌå²úÉúÇ¿ÁÒµÄÖ×Áö¿¹ÔÌØÒìÐÔÃâÒß·´Ó¦¡£HS-410»ò½«ÌṩһÖÖ¿ÉÌáÉýÖ×ÁöÃâÒßÁÆ·¨ÌØÒìÐÔµÄÈ«ÐÂ˼·¡£
ÀûÓÃÖØ×éÈÈÐݿ˵°°×gp96-ëĸ´ºÏÎÀ´»úÌå²úÉú¿¹Ö×ÁöÌØÒìÐÔÃâÒß·ÀÓù¹¦ÄÜ¡£
Heat Biologics¹«Ë¾×¨×¢ÓÚÖ×ÁöÃâÒßÁÆ·¨Ñз¢£¬ÊÇÈÈÐݿ˵°°×ÃâÒßÖÎÁÆÁìÓòµÄÁìµ¼Õß¡£¸Ã¹«Ë¾ÁìÏȵÄÈÈÐݿ˵°°×ÃâÒßÁÆ·¨£¬ÊÇ»ùÓÚÆäרÓеķº¿¹Ôϸ°û¶¾ÐÔÃâÒßÖÎÁÆ(Immune Pan-Antigen Cytotoxic Therapy, IMPACT)¼¼Êõƽ̨Ñз¢µÄ£¬ÆäÌØÕ÷ÊÇGp96ÊÇ×îÔç·¢ÏÖµÄÄܹ»ÓÕµ¼ÌØÒìÐÔÃâÒß·ÀÓù¹¦ÄܵÄÈÈÐݿ˵°°×¡£
HSP-410ÊÇHeat Biologics¹«Ë¾ÃâÒßÁÆ·¨¹ÜÏßÖеÄÏȵ¼²úÆ·¡£±¾´Î¹«²¼µÄÕâÏîÑо¿ÎªËæ»ú¡¢Ë«Ã¤¡¢°²Î¿¼Á¶ÔÕÕ2ÆÚÁÙ´²ÊÔÑ飬Èë×éÁ˷Ǽ¡²ã½þÈó°òë×°©»¼Õߣ¬ÕâЩ»¼ÕßËæ»ú½ÓÊÜ¿¨½éÃç(BCG)ÁªºÏHSP-410»òÁªºÏ°²Î¿¼ÁÖÎÁÆ¡£³õ²½½á¹ûÏÔʾ£¬HSP-410ÁªºÏÖÎÁÆÄܹ»ÓÕµ¼Ö×ÁöÏà¹Ø¿¹ÔÌØÒìÐÔÃâÒßÓ¦´ðµÄ¿É¿¿Ðźţ¬µ«³õ²½½á¹ûÉÐδ¹Û²ìµ½ÎÞ¸´·¢Éú´æ»ñÒæ¡£
2. »ÔÈðÁªÊÖIBMÎÖÉ£¬ÖúÁ¦°©Ö¢Ò©Î↑·¢
½«Ê¹ÓÃWatson·ÖÎö´óÁ¿µÄÊý¾Ý£¬°üÀ¨¹«¿ªÊý¾ÝÒÔ¼°»ÔÈðרÓÐÊý¾Ý£¬ÒÔ´ËΪ»ù´¡½øÐд´ÐÂÒ©Îï·¢ÏÖ¡£
»ÔÈð(Pfizer)ºÍIBM¹«Ë¾ÆìÏÂWatson Health½üÆÚÐû²¼½øÐкÏ×÷£¬ÀûÓÃÎÖÉÔÚ»úÆ÷ѧϰ¡¢ÓïÑÔ´¦Àí¡¢ÈÏÖª·ÖÎö·½Ãæ¼¼Êõ£¬ÒÔ°ïÖú»ÔÈðÔÚÖ×ÁöÃâÒßѧ·½Ãæ½øÕ¹£¬ÈçÐÂÒ©Îï°Ðµãʶ±ð¡¢×éºÏÁÆ·¨µÄÑо¿ºÍ»¼ÕßµÄÑ¡Ôñ²ßÂÔ¡£»ÔÈðµÄÖ×Áöר¼Ò ÓÐÁËÕâ¸öй¤¾ß£¬»ÔÈðÑо¿ÈËÔ±½«·ÖÎöºÍ²âÊÔ¼ÙÉ裬µÃµ½ÓÐÑÖ¤»ù´¡µÄ¼û½â¡£
ÕâÏîȫеÄÎÖÉÒ©Î↑·¢Æ½Ì¨(Watson for Drug Discovery)Ö¼ÔÚ°ïÖúÑо¿ÈËÔ±ÍÚ¾òеÄÒ©Îï°ÐµãºÍDZÔÚÒ©ÎïÊÊÓ¦Ö¢¡£Æ½¾ùÀ´Ëµ£¬Ñо¿ÈËÔ±ÔÚÿÄê¿ÉÔĶÁ200-300ƪÎÄÕ£¬È»¶øÎÖÉÒ©Î↑·¢Æ½Ì¨ÄÜÏêÔÄ2500ÍòƪҽѧÎÄÕª£¬³¬¹ý100ÍòҽѧÆÚ¿¯¡¢400ÍòרÀû¡£
»ÔÈðµÄ¸ß¼¶¸±×ܲ㬸ºÔðÕ½ÂÔ¡¢Í¶×Ê×éºÏºÍÉÌÒµÔËÓªLaurie OlsonÏÈÉú˵µÀ£¬ÎÒÃÇÒѾ½øÈëÒ»¸öȫеÄÊý¾Ý¿ª·¢Ê±´ú¡£ÔÚIBMÎÖɵİïÖúÏ£¬ÎÒÃÇ¿ÉÀûÓÃһϵÁÐм¼ÊõºÍÊý×Ö»¯Æ½Ì¨À´ÍÚ¾ò´óÁ¿Êý¾Ý×ÊÔ´£¬°ïÖúÎÒÃǸüºÃÁ˽⼲²¡µÄ½øÕ¹£¬²¢¸ù¾Ý»¼ÕßÌص㿪·¢³öÖ×ÁöÃâÒßÁÆ·¨×éºÏ¡£
3. Á½´ó°©Ö¢Ñо¿»ú¹¹ÁªÊÖ£¬¿ªÕ¹ÐÂ
λÓھɽðɽÅÁ¿Ë°©Ö¢ÃâÒßÁÆ·¨Ñо¿Ëù(Parker Institute for Cancer Immunotherapy)ºÍŦԼ°©Ö¢Ñо¿ÖÐÐÄ(Cancer Research Institute)Ðû²¼¿ªÕ¹ÓйØп¹ÔµÄºÏ×÷¡£Ñ°ÕÒ°©Ö¢±ê¼ÇÎï³ÉΪ½üÆÚÑо¿Öص㣬ÒòΪ¿Æѧ¼ÒÈÏΪÕâÓÐÖúÓÚÑз¢ÐÂÒ»´ú¸öÌ廯°©Ö¢ÃâÒßÁÆ·¨¡£ÕâÏîºÏ×÷±»³ÆΪTumor neoantigEn SeLection Alliance (TESLA)£¬ÄÉÈëÁËÈ«Çò30¶àλÀ´×ÔѧÊõ½çºÍ¹¤Òµ½ç°©Ö¢Ñо¿ÍŶÓÈËÔ±¡£
ÕâÏîºÏ×÷Ö¼ÔڸĽøÉúÎïÐÅϢѧËã·¨£¬Ê¹Ñо¿ÈËÔ±¸üºÃ·ÖÎöÖ×ÁöDNAºÍRNAÐòÁУ¬ÒÔ±ãÔ¤²â¿ÉÄܳöÏÖÔÚ»¼Õߵݩϸ°û±íÃæп¹Ô¡£
ͬʱ£¬ÅÁ¿Ë°©Ö¢ÃâÒßÁÆ·¨Ñо¿Ëù»¹Óë°©Ö¢Ñо¿ÖÐÐÄһͬÓëÖªÃûµÄ·ÇÓªÀûÐÔ¿Æѧ»ú¹¹Sage BionetworksÒ»¹²ºÏ×÷£¬¹²Í¬½øÐÐÊý¾Ý·ÖÎöºÍÉúÎïÐÅϢѧÑо¿¡£
¸ÃÏîÄ¿Ô¤¼ÆÊ×ÏȶÔÍíÆÚ¶ñÐÔÖ×Áö¡¢½áÖ±³¦°©ºÍ·ÇСϸ°û·Î°©½øÐÐÑо¿£¬ÒòΪÉÏÊö°©Ö¢ÀàÐÍͨ³£ÓдóÁ¿Í»±äλµã£¬Òâζןü¶àп¹Ô¿ÉÄÜÐÔ¡£Õâ´ÎÑо¿ÎüÒýÁ˸÷´ó¸ßУ¡¢ÉúÎï¼¼Êõ¹«Ë¾ºÍ¸÷´óÒ©ÆóºÍ¿Æѧ»ú¹¹¡£Ñо¿ÈËÔ±À´×Ô¸÷¸öÁìÓò£¬°üÀ¨ÃâÒßѧÁìÓò¡¢Êý¾Ý·ÖÎöÁìÓòºÍ»ùÒòѧÁìÓò¡¢·Ö×ÓÉúÎïѧºÍÎïÀíºÍ¹¤³Ìѧ¿Æ¡£ÕâÒ²ÊÇÁ½´óÖøÃû°©Ö¢Ñо¿»ú¹¹Ê×´ÎÖØ´óºÏ×÷¡£
4. À****************ñÉúÎïºÍлùÒ©Òµ¶à·¢ÐÔ¹ÇËèÁö CAR-TºòÑ¡ÁÆ·¨±íÏÖÁ¼ºÃ
B
À****************ñÉúÎï(Bluebird Bio)CAR-TºòÑ¡ÁÆ·¨bb2121ÁÙ´²Êý¾Ý£¬½üÆÚÔÚĽÄáºÚÕÙ¿ªµÚ28½ìµÄ·Ö×Ó°ÐÏòÖÎÁƺͰ©Ö¢Õï¶ÏÑÐÌÖ»á(EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium )ÉϳÊÏÖ¡££¬ÆäÔÚ1ÆÚÁÙ´²ÊÔÑéCRB-401Õ¹ÏÖ»ý¼«½á¹û¡££¬ÓÉÀ****************ñÉúÎïÓëлùÒ©Òµ(Celgene)ÁªºÏÑз¢¡£
´ËÏîСÐÍ1ÆÚÁÙ´²ÊÔÑéÒÔËÄÖÖ²»Í¬¼ÁÁ¿¶Ô¶àÃûÍíÆڶ෢ÐÔ¹ÇËèÁö»¼Õß½øÐÐÖÎÁÆ¡£ÁÙ´²ÊÔÑé½á¹ûÏÔʾ£¬½ÓÊܵͼÁÁ¿µÄ3Ãû»¼ÕßÖУ¬ÓÐ1Ãû»¼ÕßÖ×ÁöÌå»ýÓÐ50%¼õС£¬ÁíÍâ½ÓÊܸ߼ÁÁ¿µÄ6Ãû»¼Õߣ¬Í¬ÑùÖ×ÁöÌå»ýÓÐ50%¼õÉÙ¡£²¢ÇÒ£¬ÔÚ½ÓÊÜCAR-TÖ×ÁöÃâÒßÁÆ·¨2¸öÔºó£¬ÓÐ1Ãû»¼ÕßÖ×ÁöÖ¢×´ÍêÈ«»º½â¡£
À****************ñÉúÎïCMO David Davidson²©Ê¿ËµµÀ£ºÕâÏî»ý¼«ÁÙ´²Êý¾Ý±íÃ÷£¬ÎÒÃǺͺÏ×÷»ï°éлùÒ©ÒµºÏ×÷³õ²½³É¹û£¬ÎÒÃÇÔ¤¼ÆÍê³ÉÕâÏî¼ÁÁ¿µÝÔöÊÔÑéºó£¬½«¿ªÆôÏÂÒ»ÂÖÀ©´óÐÔÊÔÑé¡£
5. Âѳ²°©×éºÏÃâÒßÁÆ·¨2bÆÚÁÙ´²ÖÐÆÚ½á¹ûÁ¼ºÃ
OregovomabÓÃÓÚÖÎÁÆÍíÆÚÉÏƤÐÔÂѳ²°©¡¢¸½¼þÄÒÖ׺͸¹Ä¤°©£¬Æä×÷ÓðеãΪÖ×ÁöÏà¹Ø¿¹ÔCA125£¨Ò²³ÆΪMUC16£©¡£
OncoQuest IncרעÓÚÖ×ÁöÃâÒßÁÆ·¨²úÆ·¿ª·¢ºÍÊг¡»¯£¬½üÆÚÐû²¼ÆäÔÚÑе¥¿¹ÐÂÒ©oregovomabÔÚ2bÆÚÁÙ´²ÊÔÑéÖУ¬È¡µÃ»ý¼«ÖÐÆÚ½á¹û¡£OregovomabÊÇOncoQuestÆìϾ߸߶ÈÇ׺ÍÐÔµ¥¿¹£¬ÄܽáºÏÖÁÖ×Áöϸ°û±íÃ濹ÔCA125£¬¼¤·¢ÃâÒßϵͳ¿ªÆôһϵÁÐÃâÒß·´Ó¦¡£¸ÃÏîÁÙ´²ÊÔÑéÔÚÒâ´óÀûºÍÃÀ¹ú13¸öÁÙ´²ÖÐÐĽøÐУ¬ÊÇÒ»ÏîËæ»ú¶ÔÕÕ£¬ÓÃÒԱȽÏÒ»Ïß»¯ÁÆ·½°¸(carboplatin-paclitaxel)ºÍ»¯ÁÆÃâÒßÁªºÏÖÎÁÆ(carboplatin-paclitaxel+oregovomab)¼äÁÆЧ²îÒì¡£
97ÃûÐÂÕï¶ÏµÄתÒÆÐÔÍíÆÚÂѳ²°©»¼Õß²ÎÓëÁËÁÙ´²ÊÔÑé¡£ÁÆЧ·ÖÎöÏÔʾ£¬Óëµ¥Ò©ÖÎÁÆ×éÏà±È£¬ÁªºÏÓÃÒ©×éÔÚÁÙ´²¸´·¢ÂʺÍ×ÜÉú´æÆÚ·½Ã棬±íÏÖ³öÁËÏÔÖø¸ÄÉÆ¡£Í¬Ê±£¬°²È«ÐÔ·ÖÎöÏÔʾ£¬Á½×éÔÚ²»Á¼¸±·´Ó¦·¢ÉúÉÏÎÞÏÔÖøÐÔ²îÒì¡£¸ÃÏîÑо¿½á¹¹Ö§³Öoregovomab×÷ΪÂѳ²°©ÖÎÁÆÒ»ÏßÓÃÒ©¡£
OncoQuestµÄÊ×ϯִÐйÙMadi Madiyalakan²©Ê¿±íʾ£º ÎÒÃǶÔÓÚ´ËÏî2bÆÚÖÐÆÚÁÙ´²Êý¾Ý±íʾÂúÒâ¡£ÏÂÒ»²½£¬ÎÒÃÇ´òËãÆÀ¹ÀÆäËûÒ©ÎïÁªÓõĿÉÄÜÐÔ£¬°üÀ¨½«¸ÃÏîÖ×Áö¿¹ÔÌØÒìÐÔ¿¹ÌåÒ©ÎïÓëÆäËû¿¹°©ÁÆ·¨ÈçÃâÒß¼ìÑéµãÒÖÖƼÁºÍTollÑùÊÜÌå3¼¤¶¯¼ÁÁªÓã¬ÒÔ³ä·Ö̽Ë÷ÕâÏî¼¼ÊõµÄDZÁ¦¡£
²Î¿¼×ÊÁÏ£º
[1] Heat Biologics Presents Topline HS-410 Phase 2 Bladder Cancer Results at the Society of Urological Oncology Annual Meeting
[2] Pfizer (PFE) Turns to IBM (IBM)'s Watson to Advance Cancer Drug Discovery
[3] Tech Billionaire Sean Parker Buddies Up With Top Scientists at the Cancer Research Institute (CRI) to Sniff Out Tumors
[4] bluebird bio (BLUE), Celgene (CELG)'s Multiple Myeloma CAR-T Drug Shines in Tiny Study
[5] Oncoquest Announces Positive Interim Results From Its Phase 2b Clinical Study